Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Ijichi

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Iscience|February 17, 2023
Combination of serum human satellite RNA and miR-21-5p levels as a biomarker for pancreatic cancerTakahiro Seimiya, Tatsunori Suzuki, Takuma Iwata, et al.
Medical Oncology (Northwood, London, England)|May 31, 2018
A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancerKei Saito, Hiroyuki Isayama, Yoshihiro Sakamoto, et al.
Journal of Gastroenterology|November 2, 2011
Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progressionDai Mohri, Yoshinari Asaoka, Hideaki Ijichi, et al.
Scientific Reports|April 2, 2016
A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletionTsuneo Ikenoue, Yumi Terakado, Hayato Nakagawa, et al.
The Journal of Clinical Investigation|September 20, 2011
Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinomaHideaki Ijichi, Anna Chytil, Agnieszka E Gorska, et al.
Carcinogenesis|June 21, 2014
Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPαKeisuke Yamamoto, Keisuke Tateishi, Yotaro Kudo, et al.
World Journal of Clinical Oncology|May 26, 2011
Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancersMinoru Tada, Yousuke Nakai, Takashi Sasaki, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2013
Disease-specific mortality among patients with intraductal papillary mucinous neoplasm of the pancreasKazumichi Kawakubo, Minoru Tada, Hiroyuki Isayama, et al.
International Journal of Cancer|December 7, 2005
TRAIL-induced cell death cooperates with IFN-gamma activation in the graft-versus-tumor effect against colon tumorsKeisuke Tateishi, Miki Ohta, Bayasi Guleng, et al.
Journal of Gastroenterology|June 28, 2012
Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset ageSuguru Mizuno, Yousuke Nakai, Hiroyuki Isayama, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Iscience|February 17, 2023
Combination of serum human satellite RNA and miR-21-5p levels as a biomarker for pancreatic cancerTakahiro Seimiya, Tatsunori Suzuki, Takuma Iwata, et al.
Medical Oncology (Northwood, London, England)|May 31, 2018
A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancerKei Saito, Hiroyuki Isayama, Yoshihiro Sakamoto, et al.
Journal of Gastroenterology|November 2, 2011
Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progressionDai Mohri, Yoshinari Asaoka, Hideaki Ijichi, et al.
Scientific Reports|April 2, 2016
A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletionTsuneo Ikenoue, Yumi Terakado, Hayato Nakagawa, et al.
The Journal of Clinical Investigation|September 20, 2011
Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinomaHideaki Ijichi, Anna Chytil, Agnieszka E Gorska, et al.
Carcinogenesis|June 21, 2014
Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPαKeisuke Yamamoto, Keisuke Tateishi, Yotaro Kudo, et al.
World Journal of Clinical Oncology|May 26, 2011
Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancersMinoru Tada, Yousuke Nakai, Takashi Sasaki, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2013
Disease-specific mortality among patients with intraductal papillary mucinous neoplasm of the pancreasKazumichi Kawakubo, Minoru Tada, Hiroyuki Isayama, et al.
International Journal of Cancer|December 7, 2005
TRAIL-induced cell death cooperates with IFN-gamma activation in the graft-versus-tumor effect against colon tumorsKeisuke Tateishi, Miki Ohta, Bayasi Guleng, et al.
Journal of Gastroenterology|June 28, 2012
Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset ageSuguru Mizuno, Yousuke Nakai, Hiroyuki Isayama, et al.
Pageof 12